BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12826672)

  • 1. Influence of pH on NMR structure and stability of the human prion protein globular domain.
    Calzolai L; Zahn R
    J Biol Chem; 2003 Sep; 278(37):35592-6. PubMed ID: 12826672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR solution structure of the human prion protein.
    Zahn R; Liu A; Lührs T; Riek R; von Schroetter C; López García F; Billeter M; Calzolai L; Wider G; Wüthrich K
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):145-50. PubMed ID: 10618385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR structure of the human doppel protein.
    Lührs T; Riek R; Güntert P; Wüthrich K
    J Mol Biol; 2003 Mar; 326(5):1549-57. PubMed ID: 12595265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
    Hornemann S; Glockshuber R
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion protein fragments spanning helix 1 and both strands of beta sheet (residues 125-170) show evidence for predominantly helical propensity by CD and NMR.
    Sharman GJ; Kenward N; Williams HE; Landon M; Mayer RJ; Searle MS
    Fold Des; 1998; 3(5):313-20. PubMed ID: 9806936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
    De Gioia L; Selvaggini C; Ghibaudi E; Diomede L; Bugiani O; Forloni G; Tagliavini F; Salmona M
    J Biol Chem; 1994 Mar; 269(11):7859-62. PubMed ID: 7907586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations of human prion protein: importance of correct treatment of electrostatic interactions.
    Zuegg J; Gready JE
    Biochemistry; 1999 Oct; 38(42):13862-76. PubMed ID: 10529232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism for low pH triggered misfolding of the human prion protein.
    DeMarco ML; Daggett V
    Biochemistry; 2007 Mar; 46(11):3045-54. PubMed ID: 17315950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR structure of the mouse prion protein domain PrP(121-231).
    Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
    Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the acid-base and conformational properties of histidine residues in human prion protein (125-228) by means of pK(a) calculations and molecular dynamics simulations.
    Langella E; Improta R; Crescenzi O; Barone V
    Proteins; 2006 Jul; 64(1):167-77. PubMed ID: 16639746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR structure of the J-domain and the Gly/Phe-rich region of the Escherichia coli DnaJ chaperone.
    Pellecchia M; Szyperski T; Wall D; Georgopoulos C; Wüthrich K
    J Mol Biol; 1996 Jul; 260(2):236-50. PubMed ID: 8764403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple folding pathways for heterologously expressed human prion protein.
    Jackson GS; Hill AF; Joseph C; Hosszu L; Power A; Waltho JP; Clarke AR; Collinge J
    Biochim Biophys Acta; 1999 Apr; 1431(1):1-13. PubMed ID: 10209273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
    Dima RI; Thirumalai D
    Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion protein peptides induce alpha-helix to beta-sheet conformational transitions.
    Nguyen J; Baldwin MA; Cohen FE; Prusiner SB
    Biochemistry; 1995 Apr; 34(13):4186-92. PubMed ID: 7703230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR structure of the bovine prion protein.
    López Garcia F; Zahn R; Riek R; Wüthrich K
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8334-9. PubMed ID: 10899999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231).
    Swietnicki W; Petersen R; Gambetti P; Surewicz WK
    J Biol Chem; 1997 Oct; 272(44):27517-20. PubMed ID: 9346881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folding and intrinsic stability of deletion variants of PrP(121-231), the folded C-terminal domain of the prion protein.
    Eberl H; Glockshuber R
    Biophys Chem; 2002 May; 96(2-3):293-303. PubMed ID: 12034448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of Syrian hamster prion protein rPrP(90-231).
    Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
    Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
    Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
    Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.